Inspirion Wealth Advisors’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
Other funds holding PHAT
WA
HWAM
SAM
PMAM
YIH
SFWA
PFSRSONJ
CUAMC
Inspirion Wealth Advisors's PHAT Position: Q2 2026 in Review
Inspirion Wealth Advisors held its Phathom Pharmaceuticals (PHAT) position steady in Q2 2026 at 19,914 shares worth $210K. The position accounts for 0.02% of the portfolio, ranked #177.
Inspirion Wealth Advisors first reported a position in PHAT in Q2 2022 and has held it in 17 quarters since. The position peaked at $662K in Q3 2025. 16 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.
- Inspirion Wealth Advisors held 19,914 shares of Phathom Pharmaceuticals worth $210K as of Q2 2026.
- Inspirion Wealth Advisors left its Phathom Pharmaceuticals share count unchanged in Q2 2026.
- Phathom Pharmaceuticals made up 0.02% of Inspirion Wealth Advisors's portfolio in Q2 2026, its #177 holding.
- Inspirion Wealth Advisors first reported a position in Phathom Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
- Inspirion Wealth Advisors's Phathom Pharmaceuticals position peaked at $662K in Q3 2025.
- 16 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.
Based on Inspirion Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.